JPRN-UMIN000052954尚未招募Unknown
A dose-ranging study to confirm the reduction effect of plant extract on body fat. -Randomized, double-blind, placebo-controlled parallel group study- - A dose-ranging study to confirm the reduction effect of plant extract on body fat.
ew drug research center, Inc.0 个研究点目标入组 75 人开始时间: 2023年11月30日最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 75
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Subjects who are under treatment or have a history of severe illness in the heart, liver, kidney, digestive organs or other organs 2) Subjects who are under treatment of dyslipidemia, high blood pressure, or diabetes 3) Subjects who received medication treatment or surgery due to serious illness or injury within 1 month from the start of this study 4) Subjects who regularly use health foods and supplements affecting this study 5) Possible pregnancy, pregnancy, and lactation 6) Heavy drinkers, excessive smokers 7) Subjects who have experienced feel bad mood by blood collection 8) Subjects with systolic blood pressure less than 90 mmHg 9) Subjects who donated 200 mL or more of blood within 1 month from the start of this study or those who plan to do so during this study 10) Subjects who have been diagnosed with chronic constipation 11) Shift workers or late-night workers 12) Subjects who plan business trip or trip on average more than 10 days per month 13) Subjects who may have allergy to the ingredients contained in the test food 14) Subjects who are participating in other clinical trials, those who plan to participate during this study, and those within 1 month after the trial in which they participated 15) Subjects whose exercise habits may change significantly, those who regularly engage in strenuous exercise and those who on a diet 16) Subjects with extremely irregular eating habits 17) Subjects with claustrophobia that interferes with CT scans, subjects with metal in the CT scan measurement site due to surgery, subjects with implanted medical devices such as cardiac pacemakers, implantable cardioverter defibrillators 18) Subjects who fail to comply with the requests to subjects during the study period 19) Subjects who are ineligible due to physician's judgment
研究者
相似试验
进行中（未招募）
不适用
Study to investigate how efficient and how safe are tablets of house dust mite allergens for patients with house dust mite allergic asthmahouse dust mite-associated allergic asthmaMedDRA version: 17.0Level: LLTClassification code 10020419Term: House dust mite allergySystem Organ Class: 100000004870MedDRA version: 17.0Level: LLTClassification code 10001705Term: Allergic asthmaSystem Organ Class: 100000004855EUCTR2013-000487-28-DESTALLERGENES SA480
进行中（未招募）
1 期
Study to investigate how efficient and how safe are tablets of house dust mite allergens for patients with house dust mite allergic asthmaEUCTR2013-000487-28-DKSTALLERGENES SA480
进行中（未招募）
不适用
Study to investigate how efficient and how safe are tablets of house dust mite allergens for patients with house dust mite allergic asthmaEUCTR2013-000487-28-PLSTALLERGENES SA480
进行中（未招募）
1 期
Study to investigate how efficient and how safe are tablets of house dust mite allergens for patients with house dust mite allergic asthmahouse dust mite-associated allergic asthmaMedDRA version: 14.1Level: LLTClassification code 10020419Term: House dust mite allergySystem Organ Class: 100000004870MedDRA version: 14.1Level: LLTClassification code 10001705Term: Allergic asthmaSystem Organ Class: 100000004855EUCTR2013-000487-28-SKSTALLERGENES SA480
进行中（未招募）
不适用
Study to investigate how efficient and how safe are tablets of house dust mite allergens for patients with house dust mite allergic asthmaEUCTR2013-000487-28-CZSTALLERGENES SA480